Mitochondria-specific nanocatalysts for chemotherapy-augmented sequential chemoreactive tumor therapy

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapy

Background:

• Chemodynamic therapy (CDT) shows promise for in situ tumor treatment via the Fenton reaction.
• Limitations of monotherapy and low endogenous hydrogen peroxide (H2O2) levels in tumors hinder CDT efficacy.
• Mitochondria-specific targeting is crucial for enhanced therapeutic outcomes.

Purpose of the Study:

• To develop a mitochondria-specific nanocatalyst for chemotherapy-augmented sequential chemoreactive tumor therapy.
• To investigate the synergistic effects of cisplatin prodrug and gallic acid-ferrous (GA-Fe(II)) nanocomposites.
• To evaluate the enhanced anticancer efficiency and safety profile of the novel nanotherapy.

Main Methods:

• Fabrication of a mitochondria-specific nanocatalyst integrating cisplatin prodrug and GA-Fe(II) nanocomposites.
• Investigation of cisplatin-induced elevation of endogenous H2O2 via NOX-related pathways.
• Assessment of GA-Fe(II) nanocomposites' Fenton catalytic activity for hydroxyl radical generation.
• Evaluation of the nanocatalyst's effects on oxidative stress, mitochondrial dysfunction, AKT/mTOR signaling, and cell death in vitro and in vivo.

Main Results:

• The nanocatalyst successfully elevated endogenous H2O2 levels and generated toxic hydroxyl radicals.
• Mitochondria-specific targeting amplified oxidative stress and induced mitochondrial dysfunction.
• The treatment downregulated AKT/mTOR signaling, leading to autophagic cell death.
• Both in vitro and in vivo studies demonstrated significant anticancer efficiency with reduced side effects.

Conclusions:

• Chemotherapy-augmented sequential chemoreactive nanotherapy using mitochondria-specific nanocatalysts offers a potent strategy against tumors.
• This approach overcomes limitations of traditional CDT by enhancing H2O2 availability and targeting mitochondria.
• The developed nanotherapy shows great potential for effective and safe cancer treatment.